News & Events
-
Public Calendar: March 7-11, 2011
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
| March 7-11, 2011 | |||||
| FDA Official and Title | Date | Location | Other FDA Participants | Non-FDA Participants | Subject |
|---|---|---|---|---|---|
| Margaret A. Hamburg, M.D., Commissioner of Food and Drugs | 3/8/11 | Washington, DC | William Slikker, Jr. | N/A | Keynote address at the Society of Toxicology’s 50th Annual Meeting |
| Margaret A. Hamburg, M.D., Commissioner of Food and Drugs | 3/10/11 | Silver Spring, MD | Lawrence Deyton, Michael R. Taylor, Luciana Borio, Michele Mital, Larry Bachorik, Joseph Reardon | John Auerbach, Clayton Earl Hunter, Paul Halverson, Mary Selecky, Jose Montero (Association of State and Territorial Health Officials [ASTHO]) | Food Safety, Menu Labeling, Implementation of the Family Smoking Prevention and Tobacco Control Act and Shelf-life Extension of Medical Countermeasures |
| John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Dara A. Corrigan, Associate Commissioner for Regulatory Affairs | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Curtis L. Coy, Deputy Commissioner for Administration | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine | 3/8/11 | Washington, DC | N/A | N/A | United States Animal Health Association and American Association of Veterinary Laboratory Diagnosticians Annual Committee on Government Relations Meeting |
| Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health | 3/8/11 | Silver Spring, MD | Ralph Tyler, David Roeder, Donald Beers, Peter Beckman, Luciana Borio, Martha Monser | Several representatives from Gates Foundation, Bio Ventures Global Health, Allow Ventures, Merck and Co., Novartis, iOne World Health and TB Alliances | Priority Review Voucher (PRV) |
| Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health | 3/10/11 | Washington, DC | Janet Woodcock, Lawrence J. Lesko, Julie Zawisza | Several representatives from private industry and pharmaceutical companies | Speech at rEVOLUTION 2011- The Sixth Annual Symposium for Chief Scientific Officers Focused on Drug R&D Issues |
| Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition | 3/10/11 | College Park, MD | Linda Katz, Mitch Cheeseman, Andrew Zajac, Tracey Sanders | Stuart Pope (Patton Boggs, LLP); Mel Drozen (Keller and Heckman); Peter Hutt (Covington and Burling, LLP); Sten Rizk, Doreothy Lagg (Mars Incorporated) | Color Additive Approval Process |
| Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition | 3/11/11 | College Park, MD | Berhane Girmay, Judith Kraus, Grace Kim | David Rosenthal, Audrae Erickson (Corn Refiners Association); Clausen Ely (Covington and Burling, LLP) | High Fructose Corn Sugar Co-labeling |
| Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs | 3/8/11 | Silver Spring, MD | N/A | Vincent Ahonkhai (Gates Foundation) | International Issues |
| Beth Martino, Associate Commissioner for External Affairs | 3/7/11 | Silver Spring, MD | Meghan Scott | David Carter, Kelly Dencker, Kevin Lamb (Coyne Public Relations) | Media and Social Media Metrics |
| Beth Martino, Associate Commissioner for External Affairs | 3/9/11 | Silver Spring, MD | Meghan Scott, Heidi Rebello, Michael Herndon | Felice Freyer, Kathryn Foxhall (Association of Health Care Journalists) | FDA Media Policy |
| Beth Martino, Associate Commissioner for External Affairs | 3/9/11 | Silver Spring, MD | Meghan Scott | Bill Beaman (OnPoint Strategies) | Writing |
| Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Ralph Tyler, J.D., Chief Counsel | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs | 3/7/11-3/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research | 3/10/11 | Bethesda, MD | ShaAvhree Buckman, George Rochester, Stephen Wilson, Robert Temple | Andreas Bruckner (Bayer- Schering Pharma); Harry Seifert (GlaxoSmithKline Biologicals); Steve Snapinn (Amgen, Inc.); Kay Dickersin (John Hopkins University) | DIA/FDA Best Practices for Regulatory Information Synthesis of Randomized Controlled Trials for Product Safety Evaluation |
| Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research | 3/10/11 | Rockville, MD | David Jacobson-Kram, Donna Mendrick | Christopher Austin (National Institute of Health) | Tox 21 General Meeting |
-
-
